PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of postmedjPostgraduate Medical JournalVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Postgrad Med J. 1994 August; 70(826): 584–588.
PMCID: PMC2397683

Dexamethasone-suppressible feminizing adrenal adenoma.

Abstract

A 39 year old man presented with gynaecomastia, loss of libido and high blood pressure. Hormone studies revealed elevated plasma levels of oestradiol and its precursors, which increased in response to adrenocorticotrophic hormone and were reduced to normal levels with dexamethasone. Computed tomography disclosed a left adrenal mass and surgery was performed. The removed tumour weighed 84 g and the histological diagnosis was of adenoma. Nine years after surgery, he is asymptomatic, without hypertension, and radiological and or hormonal evidence of recurrence. We discuss the hormone profile in this case and the dynamics of steroid production by the tumour which, in contrast to the classical concept of tumour autonomy, showed dependence of oestradiol secretion on endogenous adrenocorticotrophic hormone.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (906K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • GABRILOVE JL, SHARMA DC, WOTIZ HH, DORFMAN RI. FEMINIZING ADRENOCORTICAL TUMORS IN THE MALE. A REVIEW OF 52 CASES INCLUDING A CASE REPORT. Medicine (Baltimore) 1965 Jan;44:37–79. [PubMed]
  • Veldhuis JD, Sowers JR, Rogol AD, Klein FA, Miller N, Dufau ML. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. N Engl J Med. 1985 May 23;312(21):1371–1375. [PubMed]
  • Freeman DA. Steroid hormone-producing tumors in man. Endocr Rev. 1986 May;7(2):204–220. [PubMed]
  • Barcelo B, Abascal J, Ardaiz J, Gil P, Colas A, Menendez J, Inchausti JL. Feminizing adrenocortical carcinoma in a postmenopausal woman. Postgrad Med J. 1979 Jun;55(644):406–408. [PMC free article] [PubMed]
  • McKenna TJ, O'Connell Y, Cunningham S, McCabe M, Culliton M. Steroidogenesis in an estrogen-producing adrenal tumor in a young woman: comparison with steroid profiles associated with cortisol- and androgen-producing tumors. J Clin Endocrinol Metab. 1990 Jan;70(1):28–34. [PubMed]
  • Howard CP, Takahashi H, Hayles AB. Feminizing adrenal adenoma in a boy. Case report and literature review. Mayo Clin Proc. 1977 Jun;52(6):354–357. [PubMed]
  • Itami RM, Amundson GM, Kaplan SA, Lippe BM. Prepubertal gynecomastia caused by an adrenal tumor. Diagnostic value of ultrasonography. Am J Dis Child. 1982 Jul;136(7):584–586. [PubMed]
  • Desai MB, Kapadia SN. Feminizing adrenocortical tumors in male patients: adenoma versus carcinoma. J Urol. 1988 Jan;139(1):101–103. [PubMed]
  • Bhettay E, Bonnici F. Pure oestrogen-secreting feminizing adrenocortical adenoma. Arch Dis Child. 1977 Mar;52(3):241–243. [PMC free article] [PubMed]
  • Bacon GE, Lowrey GH. Feminizing adrenal tumor in a six-year-old boy. J Clin Endocrinol Metab. 1965 Oct;25(10):1403–1406. [PubMed]
  • Gabrilove JL, Nicolis GL, Hausknecht RU, Wotiz HH. Feminizing adrenocortical carcinoma in a man. Cancer. 1970 Jan;25(1):153–160. [PubMed]
  • Valensi P, Coussieu C, Kemeny JL, Attali JR, Amouroux J, Sebaoun J. Endocrine investigations in two cases of feminizing Leydig cell tumour. Acta Endocrinol (Copenh) 1987 Jul;115(3):365–372. [PubMed]
  • Solomon SS, Swersie SP, Paulsen CA, Biglieri EG. Feminizing adrenocortical carcinoma with hypertension. J Clin Endocrinol Metab. 1968 May;28(5):608–612. [PubMed]
  • Cathelineau G, Poizat R. Tumeur féminisante de la surrénale avec hyperaldostéronisme primaire et hypertension artérielle maligne. Evolution terminale. Ann Endocrinol (Paris) 1976 Jan-Feb;37(1):59–60. [PubMed]
  • McAreavey D, Cumming AM, Boddy K, Brown JJ, Fraser R, Leckie BJ, Lever AF, Morton JJ, Robertson JI, Williams ED. The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives. Clin Endocrinol (Oxf) 1983 Feb;18(2):111–118. [PubMed]
  • Klein FA, Miller NL, Hackler RH. Flow cytometry in feminizing adrenocortical carcinoma. J Urol. 1985 Nov;134(5):933–935. [PubMed]
  • Comite F, Schiebinger RJ, Albertson BD, Cassorla FG, Vander Ven K, Cullen TF, Loriaux DL, Cutler GB., Jr Isosexual precocious pseudopuberty secondary to a feminizing adrenal tumor. J Clin Endocrinol Metab. 1984 Mar;58(3):435–440. [PubMed]
  • Freeman DA. Steroid hormone-producing tumors of the adrenal, ovary, and testes. Endocrinol Metab Clin North Am. 1991 Dec;20(4):751–766. [PubMed]
  • Mersey JH, Ceballos L, Levin P, Busky S. Estrogen-secreting adrenal tumor responsive to ACTH: localization by adrenal venous sampling. South Med J. 1988 Feb;81(2):275–278. [PubMed]
  • Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med. 1981 Nov;71(5):855–875. [PubMed]
  • Saez JM, Dazord A, Gallet D. ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site. J Clin Invest. 1975 Sep;56(3):536–547. [PMC free article] [PubMed]
  • Hsueh AJ, Erickson GF. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids. 1978 Dec;32(5):639–648. [PubMed]
  • Gabrilove JL, Nicolis GL, Sohval AR. Non-tumorous feminizing adrenogenital syndrome in the male subject. J Urol. 1973 Dec;110(6):710–713. [PubMed]
  • Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF, Abrams HL. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol. 1985 Jan;144(1):61–65. [PubMed]
  • Schteingart DE, Oberman HA, Friedman BA, Conn JW. Adrenal cortical neoplasms producing cushing's syndrome. A clinicopathologic study. Cancer. 1968 Nov;22(5):1005–1013. [PubMed]
  • King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer. 1979 Jul;44(1):239–244. [PubMed]
  • LIPSETT MB, HERTZ R, ROSS GT. CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA. Am J Med. 1963 Sep;35:374–383. [PubMed]
  • Minowada S, Kinoshita K, Hara M, Isurugi K, Uchikawa T, Niijima T. Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma. Endocrinol Jpn. 1985 Feb;32(1):29–37. [PubMed]
  • Gröndal S, Eriksson B, Hagenäs L, Werner S, Curstedt T. Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol (Copenh) 1990 May;122(5):656–663. [PubMed]
  • Aupetit-Faisant B, Battaglia C, Zenatti M, Emeric-Blanchouin N, Legrand JC. Hypoaldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma. J Clin Endocrinol Metab. 1993 Jan;76(1):38–43. [PubMed]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Group